October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

C7A Malignant neuroendocrine tumors

All 23 codes in the C7A family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in family

23

Can lead a claim

22

Cannot lead a claim

1

What CMS assigns to C7A

22 of the 23 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases; 1 is assigned no clinical group. 22 of the 23 count toward the Merkel Cell and Neuroendocrine Carcinoma comorbidity subgroup; 1 is assigned none. 22 of the 23 can lead a claim.

  • Merkel Cell and Neuroendocrine Carcinoma

Every code in C7A

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
C7A.0 Malignant carcinoid tumors
C7A.00Malignant carcinoid tumor of unspecified siteCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
C7A.01 Malignant carcinoid tumors of the small intestine
C7A.010Malignant carcinoid tumor of the duodenumCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.011Malignant carcinoid tumor of the jejunumCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.012Malignant carcinoid tumor of the ileumCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.019Malignant carcinoid tumor of the small intestine, unspecified portionCMS: Malignant carcinoid tumor of the sm int, unsp portionCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.02 Malignant carcinoid tumors of the appendix, large intestine, and rectum
C7A.020Malignant carcinoid tumor of the appendixCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.021Malignant carcinoid tumor of the cecumCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.022Malignant carcinoid tumor of the ascending colonCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.023Malignant carcinoid tumor of the transverse colonCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.024Malignant carcinoid tumor of the descending colonCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.025Malignant carcinoid tumor of the sigmoid colonCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.026Malignant carcinoid tumor of the rectumCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.029Malignant carcinoid tumor of the large intestine, unspecified portionCMS: Malignant carcinoid tumor of the lg int, unsp portionCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.09 Malignant carcinoid tumors of other sites
C7A.090Malignant carcinoid tumor of the bronchus and lungCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.091Malignant carcinoid tumor of the thymusCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.092Malignant carcinoid tumor of the stomachCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.093Malignant carcinoid tumor of the kidneyCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.094Malignant carcinoid tumor of the foregut, unspecifiedCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.095Malignant carcinoid tumor of the midgut, unspecifiedCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.096Malignant carcinoid tumor of the hindgut, unspecifiedCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.098Malignant carcinoid tumors of other sitesCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.1Malignant poorly differentiated neuroendocrine tumorsCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma
C7A.8Other malignant neuroendocrine tumorsCan lead a claimKMerkel Cell and Neuroendocrine Carcinoma

Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue